ethylmaleimide has been researched along with Hemochromatosis in 1 studies
Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies.
Hemochromatosis: A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mürer, EH | 1 |
| Holme, R | 1 |
1 other study available for ethylmaleimide and Hemochromatosis
| Article | Year |
|---|---|
A study of the release of calcium from human blood platelets and its inhibition by metabolic inhibitors. N-ethylmaleimide and aspirin.
Topics: Adenine Nucleotides; Antimycin A; Aspirin; Blood Platelets; Calcium; Calcium Isotopes; Ethylmaleimid | 1970 |